These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21620053)

  • 1. Proteinuria is a predictor of posttransplant anemia.
    Bonofiglio R; Lofaro D; Greco R; Senatore M; Papalia T
    Transplant Proc; 2011 May; 43(4):1063-6. PubMed ID: 21620053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing levels of hemoglobin improve renal transplantation outcomes.
    Lofaro D; Greco R; Papalia T; Bonofiglio R
    Transplant Proc; 2011 May; 43(4):1036-8. PubMed ID: 21620046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
    Luna E; Cerezo I; Macias R; Villa J; Martinez C; Cubero J; Martinez R; Ferreira F; García C
    Transplant Proc; 2011; 43(6):2187-90. PubMed ID: 21839229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis.
    Jones H; Talwar M; Nogueira JM; Ugarte R; Cangro C; Rasheed H; Klassen DK; Weir MR; Haririan A
    Transplantation; 2012 May; 93(9):923-8. PubMed ID: 22377790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anemia control in renal transplant recipients receiving continuous erythropoietin receptor activator (C.E.R.A.) treatment: the AnemiaTrans Study.
    Sánchez-Fructuoso AI; Ruiz JC; Torregrosa JV; González E; Gómez E; Gallego RJ; Troya MI; Jimenez C; Llamas F; Romero R; Bernis C; Crespo JF; Guirado L;
    Adv Ther; 2012 Nov; 29(11):979-91. PubMed ID: 23160946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of anemia with erythropoietin-stimulating agents in kidney transplant recipients and chronic kidney disease-another drawback of immunosuppression?
    Malyszko J; Glowinska I; Mysliwiec M
    Transplant Proc; 2012 Dec; 44(10):3013-6. PubMed ID: 23195016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence and management of anemia in renal transplantation: an observational-French study].
    Choukroun G; Deray G; Glotz D; Lebranchu Y; Dussol B; Bourbigot B; Lefrançois N; Cassuto-Viguier E; Toupance O; Hacen C; Lang P; Mazouz H; Martinez F
    Nephrol Ther; 2008 Dec; 4(7):575-83. PubMed ID: 18672417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia at 1 year after kidney transplantation has a negative long-term impact on graft and patient outcomes.
    Marcén R; Galeano C; Fernandez-Rodriguez A; Jiménez S; Teruel JL; Burgos FJ; Quereda C
    Transplant Proc; 2012 Nov; 44(9):2593-5. PubMed ID: 23146465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria and hemoglobin levels in patients with primary glomerular disease.
    Mähr N; Neyer U; Prischl F; Kramar R; Mayer G; Kronenberg F; Lhotta K
    Am J Kidney Dis; 2005 Sep; 46(3):424-31. PubMed ID: 16129203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia in living donor kidney transplantation.
    Sert I; Colak H; Tugmen C; Dogan SM; Karaca C
    Transplant Proc; 2013; 45(6):2238-43. PubMed ID: 23714109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of very early high doses of recombinant erythropoietin on anemia and allograft function in de novo kidney-transplant patients.
    Kamar N; Reboux AH; Cointault O; Esposito L; Cardeau-Desangles I; Lavayssière L; Guitard J; Wéclawiak H; Rostaing L
    Transpl Int; 2010 Mar; 23(3):277-84. PubMed ID: 19821956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An underappreciated problem in renal transplant recipients: anemia.
    Unal A; Sipahioglu MH; Akcakaya M; Tokgoz B; Sav T; Oymak O; Utas C
    Transplant Proc; 2008 Jun; 40(5):1399-403. PubMed ID: 18589116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of living kidney donors over the past 28 years in a single center in Taiwan.
    Tsai SF; Shu KH; Ho HC; Wu MJ; Cheng CH; Lian JD; Wen MC; Su CK; Yu TM; Chuang YW; Huang ST; Chen CH
    Transplant Proc; 2012 Jan; 44(1):39-42. PubMed ID: 22310573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective protocol-based trial of darbepoetin alfa therapy to correct the early anemia following renal transplantation.
    Pankewycz O; Kulaylat M; Fagan L; Matthews B; Kohli R; Laftavi MR
    Transplant Proc; 2010 Nov; 42(9):3537-41. PubMed ID: 21094811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting erythropoietin stimulating agents for persistent anemia after kidney transplant: risk factors and outcome.
    Al-Otaibi T; Gheith O; Halim MA; Abu Attia H; Mansour H; Said T; Nair P; Balaha M; Nampoory MR
    Exp Clin Transplant; 2014 Jun; 12(3):220-6. PubMed ID: 24907722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pre-transplantation hemoglobin concentration on prognosis of renal transplant recipients.
    Na N; Hong LQ; Miao B; Hua XF; Huang ZY
    Chin Med J (Engl); 2011 Apr; 124(8):1213-6. PubMed ID: 21542999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration.
    Lawler EV; Gagnon DR; Fink J; Seliger S; Fonda J; Do TP; Gaziano JM; Bradbury BD
    Nephrol Dial Transplant; 2010 Jul; 25(7):2237-44. PubMed ID: 20083469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.